BDNF and depressive disorder: In planning future investigations about the neurotrophic hypothesis of depressive disorder among a bigger cohort, more biomarkers (for example, blood eosinophilia and brain-derived neurotropic factor—BDNF) or clinical tests (for example, flow cytometry) should also be included to identify certain immunology markers.